19 results on '"A. van Tienhoven"'
Search Results
2. Nationwide prospective audit of pancreatic surgery: design, accuracy, and outcomes of the Dutch Pancreatic Cancer Audit
3. Preoperative Radiotherapy on the Transection Margin in Patients at High Risk of Pancreatic Fistula after Pancreatoduodenectomy (FIBROPANC): A Multicenter Phase II Study
4. Neoadjuvant FOLFIRINOX versus Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy for Resectable and Borderline Resectable Pancreatic Cancer: Update on the Nationwide Multicenter PREOPANC-2 Randomized Trial
5. Improved Overall Survival in Pancreatic Cancer with Preoperative Chemoradiotherapy: Long-term Results of the PREOPANC Trial
6. Preoperative chemoradiotherapy diminishes the risk of postoperative pancreatic fistula after pancreatoduodenectomy
7. High-dose stereotactic body radiotherapy by real-time MRI guided tracking for locally advanced or recurrent pancreatic cancer: prospective single-center study
8. Surgical Complications after Preoperative Chemoradiotherapy in Patients with Resectable and Borderline Resectable Pancreatic Cancer in a Multicentre, Randomised Controlled Clinical Trial (PREOPANC-1)
9. Surgical Complications after Preoperative Chemoradiotherapy in Patients with Resectable and Borderline Resectable Pancreatic Cancer in a Multicentre, Randomised Controlled Clinical Trial (PREOPANC-1)
10. Neoadjuvant FOLFIRINOX versus Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy for Resectable and Borderline Resectable Pancreatic Cancer: Update on the Nationwide Multicenter PREOPANC-2 Randomized Trial
11. Improved Overall Survival in Pancreatic Cancer with Preoperative Chemoradiotherapy: Long-term Results of the PREOPANC Trial
12. High-dose stereotactic body radiotherapy by real-time MRI guided tracking for locally advanced or recurrent pancreatic cancer: prospective single-center study
13. Preoperative chemoradiotherapy diminishes the risk of postoperative pancreatic fistula after pancreatoduodenectomy
14. Nationwide trends in incidence, treatment and survival of patients with pancreatic cancer in the past two decades
15. Neoadjuvant FOLFIRINOX versus neoadjuvant chemoradiotherapy and adjuvant chemotherapy for (borderline) resectable pancreatic cancer: Update on the PREOPANC-2 study
16. Nationwide trends in incidence, treatment and survival of patients with pancreatic cancer in the past two decades
17. Neoadjuvant FOLFIRINOX versus neoadjuvant chemoradiotherapy and adjuvant chemotherapy for (borderline) resectable pancreatic cancer: Update on the PREOPANC-2 study
18. Nationwide prospective audit of pancreatic surgery: design, accuracy, and outcomes of the Dutch Pancreatic Cancer Audit
19. Neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy for borderline resectable and resectable pancreatic cancer (PREOPANC-2): a multicenter randomized controlled trial.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.